CanFinis Therapeuticsmetastatic gastric cancersolid tumorsChimeric Antigen Receptor T-cell (CAR-T) therapyhematologic malignancies
…ogeneous tumor microenvironment (TME). To address this problem, CanFinis Therapeutics has developed a proprietary ex vivo TME derived humanised platf…